The accessories segment by product is estimated to lead the market growth during the forecast period.

According to a new market research study of “Europe Intravascular Ultrasound (IVUS) Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Modality, Product, End User and Country.” The Europe intravascular ultrasound devices market is expected to reach US$ 299.92 million by 2028 from US$ 183.95 million in 2021; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028. The report highlights trends prevailing in the Europe intravascular ultrasound devices market and the factors driving market along with those that act as hindrances.

Cardiovascular diseases (CVDs) continue to be the most significant cause of morbidity and mortality worldwide. CVDs affect heart and blood vessels, and include coronary heart disease, arrhythmias, and other conditions. Unhealthy diet is one of the most important lifestyle factors that lead to cardiovascular diseases. The growing prevalence of arrhythmia and other cardiovascular diseases (CVDs) is encouraging the introduction of improved diagnostic methods. Intravascular Ultrasound Devices (IVUS) are the most effective instruments for detecting coronary artery disease, and other related conditions. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, with 17.9 million deaths caused in the world each year; moreover, 30 million people suffer from stroke every year. According to the WHO factsheets, ~17.7 million people died due to CVDs in 2017, of which ~7.4 million mortalities were due to coronary heart disease and 6.7 million were due to stroke.

Furthermore, the European Society of Cardiology reported that coronary heart disease is a commonly found condition in the region, and the patients suffering from coronary heart disease are at a five-time greater risk of getting a stroke. A few of the primary risk factors of CVDs include family history, ethnicity, age, and other risk factors: tobacco consumption, hypertension, obesity, high cholesterol, physical inactivity, diabetes, unhealthy diets, and alcohol consumption. The majority of CVDs can be prevented through pre-monitoring and pre-diagnosis using intravascular ultrasound devices. Therefore, the growing number of CVDs is propelling the demand for intravascular ultrasound devices.

The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries and number of deaths were also high. The World Health Organization confirmed COVID-19 as a pandemic in March 2020. Since then, millions of patients worldwide have had their care delayed as hospitals canceled non-urgent operations, including some surgeries for people with heart and lung conditions. As a result, every region around the world has experienced record low numbers for angiographies and angioplasties in 2020. For instance, in Spain, angioplasty procedures were down 40% within the first week of the lockdown in April. There were also 48% fewer diagnostic examinations and 81% fewer trans catheter procedure interventions. Lombardy, one of Italy’s worst affected regions, shut down 80% of its cardiac surgical units to preserve resources for emergency COVID-related cases.

The unprecedented impact of COVID-19 has been far-reaching, but the effects on cancer patients make them one of the worst affected groups. COVID-19 has profoundly impacted the number of patients undergoing cancer screening, diagnosis, and treatment. The increased pressure due to the growing rate of COVID-19 patients' hospitalization led to the re-profiling of many hospitals and departments, including oncology clinics for treating patients with the COVID-19. Consequently, according to one study, many diagnostic and treatment procedures had been cancelled or postponed around the world, including as many as 2.3 million surgeries.

The Europe intravascular ultrasound device market based on the application was segmented into virtual histology IVUS, iMap IVUS, and integrated backscatter IVUS. The Europe intravascular ultrasound device market, based on product is segmented into equipment and accessories. The accessories segment is further sub-segmented into catheters, guidewires, and others. Geographically, the Europe intravascular ultrasound device market is sub-segmented into Germany, Spain, Italy, UK, France and Rest of Europe.

Koninklijke Philips N.V, GE Healthcare, Siemens AG, Boston Scientific Corporation, Infraredx, Inc., Terumo Corporation, Axle International, Conavi Medical Inc., Canon Medical Systems, and Abbott are among the leading companies operating in the Europe iintravascular ultrasound device market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com